Organon ANZ submission to the Senate Select Committee Inquiry on Women’s Health

Save Print

October 15, 2026 1:35 pm EDT

October 2026

Organon Australia and New Zealand (Organon ANZ) welcome and commend the Senate Select Committee on Women’s Health and the enduring prioritisation of women’s health by the Government. 

Organon is a global healthcare company dedicated to women’s health. With a portfolio spanning more than 70 medicines and products across reproductive health, fertility, and other therapeutic areas relevant to women throughout their lives, Organon believes women are foundational to a healthier world. We envision a better and healthier every day for every woman.

We are proud of our long-standing record of contributing evidence and policy analysis to Australian women’s health reform, including a 2022 submission to the Senate Inquiry into Universal Access to Reproductive Healthcare and Organon-commissioned research into the prevalence and cost of unintended pregnancy in Australia.

Our submission for this Select Committee includes 9 recommendations in the areas of assisted reproductive technology and contraception, including:

  • Introduction of a Medicare rebate for elective fertility preservation (EFP), distinct from existing medically indicated item numbers.
  • Introduction of an cost-offset mechanism for elective fertility preservation (EFP), such as a means-tested rebate or tax offset.
  • Investment in national reproductive health literacy program and primary care counselling to support informed reproductive decision-making.
  • Support and promotion of employer-sponsored fertility reimbursement schemes including non-medical egg freezing through tax guidance, so access is not limited to employees of large employers.
  • Embedding of contraceptive counselling, planning and provision as a standard component of maternity care. Develop and implement nationally consistent clinical guidance on postpartum contraception, integrated within antenatal, maternity and postnatal care pathways.
  • Expanding of MBS support for contraceptive counselling during pregnancy and the postpartum period, and ensure appropriate remuneration for contraceptive procedures, including long-acting reversible contraception (LARC) insertion and removal.
  • Implementation of contraceptive workforce training and education, embed contraceptive care competencies across health professional curricula, and enable appropriately trained specialists, GPs, midwives, nurses, nurse practitioners and Aboriginal Health Practitioners to provide contraceptive counselling and provision within their scope of practice.
  • Investment in nationally consistent, evidence-based reproductive health education and contraceptive resources before and after birth. Ensure information is accessible, culturally safe, and supports informed decision-making.
  • Enhancement of awareness, implementation and uptake of existing and future Government initiatives that support access to effective contraception, including targeted education and communication campaigns for healthcare professionals and the public.